Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Genfit SA (NASDAQ:GNFT) has agreed to acquire the Swiss startup Versantis for CHF40 million upfront in a small-time buyout. The deal,…
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
Pre-open movers
U.S. stock futures traded higher in early pre-market trade on Wednesday after recording sharp losses on Tuesday following the release of inflation data for August. All the three major indices settled sharply lower, notching their biggest single-session percentage declines since June 2020.
BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Important Biotech Catalysts For September 13, 2022 – End Of The Day Summary
Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety…
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to GENFIT’s (NASDAQ: GNFT) drug candidate GNS5611 (ezurpimtrostat) for the treatment of cholangiocarcinoma.
Analyzing Genfit’s Short Interest
Genfit's (NASDAQ:GNFT) short percent of float has risen 15.09% since its last report. The company recently reported that it has 296 thousand shares sold short, which is 0.61% of all regular shares that are available for trading.
38 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies.
55 Biggest Movers From Friday
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.